Rockefeller Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,873
| Closed | -$419K | – | 1677 |
|
|
2024
Q2 | $419K | Sell |
15,873
-4,129
| -21% | -$109K | ﹤0.01% | 1486 |
|
|
2024
Q1 | $607K | Sell |
20,002
-672,962
| -97% | -$20.4M | ﹤0.01% | 1412 |
|
|
2023
Q4 | $19.5M | Buy |
692,964
+663,963
| +2,289% | +$18.7M | 0.07% | 295 |
|
|
2023
Q3 | $787K | Buy |
29,001
+3,940
| +16% | +$107K | ﹤0.01% | 1167 |
|
|
2023
Q2 | $770K | Buy |
25,061
+171
| +0.7% | +$5.26K | ﹤0.01% | 1181 |
|
|
2023
Q1 | $896K | Sell |
24,890
-69,113
| -74% | -$2.49M | ﹤0.01% | 1120 |
|
|
2022
Q4 | $3.72M | Sell |
94,003
-9,257
| -9% | -$366K | 0.02% | 585 |
|
|
2022
Q3 | $4.15M | Buy |
103,260
+3,373
| +3% | +$136K | 0.02% | 579 |
|
|
2022
Q2 | $4.2M | Sell |
99,887
-219
| -0.2% | -$9.21K | 0.02% | 565 |
|
|
2022
Q1 | $3.9M | Sell |
100,106
-26,517
| -21% | -$1.03M | 0.02% | 601 |
|
|
2021
Q4 | $5.05M | Buy |
126,623
+44,797
| +55% | +$1.78M | 0.02% | 536 |
|
|
2021
Q3 | $2.96M | Buy |
81,826
+66,250
| +425% | +$2.39M | 0.02% | 635 |
|
|
2021
Q2 | $638K | Buy |
15,576
+3,072
| +25% | +$126K | ﹤0.01% | 1094 |
|
|
2021
Q1 | $545K | Sell |
12,504
-1,359
| -10% | -$59.2K | ﹤0.01% | 990 |
|
|
2020
Q4 | $693K | Buy |
13,863
+9,339
| +206% | +$467K | 0.01% | 806 |
|
|
2020
Q3 | $190K | Buy |
4,524
+2,524
| +126% | +$106K | ﹤0.01% | 1054 |
|
|
2020
Q2 | $97K | Buy |
+2,000
| New | +$97K | ﹤0.01% | 1179 |
|